These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 4992740

  • 1. [Significance of immunosuppression for the origin and growth of malignant tumors].
    Reis HE.
    Dtsch Med Wochenschr; 1971 Jan 22; 96(4):170-4. PubMed ID: 4992740
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The role of immunosuppression in the genesis and growth of malignant tumours.
    Reis HE.
    Ger Med Mon; 1971 Jan 22; 1(1):16-21. PubMed ID: 4931500
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Immunological supervision and carcinogenesis].
    Gorelik LS.
    Usp Sovrem Biol; 1975 Jan 22; 80(2):270-86. PubMed ID: 55009
    [No Abstract] [Full Text] [Related]

  • 7. [Immunosuppression mechanism affecting the development of neoplasms].
    Rupniewska ZM, Kurowska M.
    Pol Tyg Lek; 1980 Mar 24; 35(12):455-7. PubMed ID: 6966796
    [No Abstract] [Full Text] [Related]

  • 8. Malignancy as a complication of immunosuppressive therapy.
    Leibowitz S, Schwartz RS.
    Adv Intern Med; 1971 Mar 24; 17():95-123. PubMed ID: 4145004
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunology in neoplasia relating to diagnosis, therapy and transplantation. Immunosuppression and oncogenesis.
    Cerilli J, Hattan D.
    Am J Clin Pathol; 1974 Aug 24; 62(2):218-23. PubMed ID: 4602088
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Chronic antigenic stimulation as a pathogenic factor in the development of malignant lymphoma].
    Myking AO.
    Nord Med; 1971 May 27; 85(21):645-9. PubMed ID: 5581410
    [No Abstract] [Full Text] [Related]

  • 14. Immunological disorders in the aetiology of lymphoreticular neoplasms.
    Hoerni B, Laporte G.
    Rev Eur Etud Clin Biol; 1970 Oct 27; 15(8):841-50. PubMed ID: 4924913
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Malignant neoplasms after organ transplantation].
    Mol'kov IuN, Golikova SD, Balakirev EM.
    Vopr Onkol; 1980 Oct 27; 26(11):107-13. PubMed ID: 7006209
    [No Abstract] [Full Text] [Related]

  • 18. [Problems of tumor immunology and immunotherapy].
    Schmidt CG.
    Helv Chir Acta; 1973 Mar 27; 40(1):77-86. PubMed ID: 4540691
    [No Abstract] [Full Text] [Related]

  • 19. [Humoral immune deficiency in paraproteinemias].
    Mordasini RC, Keller H, Schlumpf E, Riva G.
    Schweiz Med Wochenschr; 1972 May 06; 102(18):625-35. PubMed ID: 4624420
    [No Abstract] [Full Text] [Related]

  • 20. [Immunosuppression, genesis and growth of malignant tumours].
    Reis HE.
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972 May 06; 78(1):42-50. PubMed ID: 4264377
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.